UNLABELLED: Treacher Collins syndrome (TCS) is the most common and well-known mandibulofacial dysostosis caused by mutations in at least three genes involved in pre-rRNA transcription, the TCOF1, POLR1D and POLR1C genes. We present a severely affected male individual with TCS with a heterozygous de novo frameshift mutation within the TCOF1 gene (c.790_791delAG,p.Ser264GlnfsX7) and compare the clinical findings with three previously unpublished, milder affected individuals from two families with the same mutation. We elucidate typical clinical features of TCS and its clinical implications for the paediatrician and mandibulofacial surgeon, especially in severely affected individuals and give a short review of the literature. CONCLUSION: The clinical data of these three families illustrate that the phenotype associated with this specific mutation has a wide intra- and interfamilial variability, which confirms that variable expressivity in carriers of TCOF1 mutations is not a simple consequence of the mutation but might be modified by the combination of genetic, environmental and stochastic factors. Being such a highly complex disease treatment of individuals with TCS should be tailored to the specific needs of each individual, preferably by a multidisciplinary team consisting of paediatricians, craniofacial surgeons and geneticists.
UNLABELLED: Treacher Collins syndrome (TCS) is the most common and well-known mandibulofacial dysostosis caused by mutations in at least three genes involved in pre-rRNA transcription, the TCOF1, POLR1D and POLR1C genes. We present a severely affected male individual with TCS with a heterozygous de novo frameshift mutation within the TCOF1 gene (c.790_791delAG,p.Ser264GlnfsX7) and compare the clinical findings with three previously unpublished, milder affected individuals from two families with the same mutation. We elucidate typical clinical features of TCS and its clinical implications for the paediatrician and mandibulofacial surgeon, especially in severely affected individuals and give a short review of the literature. CONCLUSION: The clinical data of these three families illustrate that the phenotype associated with this specific mutation has a wide intra- and interfamilial variability, which confirms that variable expressivity in carriers of TCOF1 mutations is not a simple consequence of the mutation but might be modified by the combination of genetic, environmental and stochastic factors. Being such a highly complex disease treatment of individuals with TCS should be tailored to the specific needs of each individual, preferably by a multidisciplinary team consisting of paediatricians, craniofacial surgeons and geneticists.
Authors: Wolfgang Buchenau; Michael S Urschitz; Judit Sautermeister; Margit Bacher; Tina Herberts; Joerg Arand; Christian F Poets Journal: J Pediatr Date: 2007-06-22 Impact factor: 4.406
Authors: F A Shah; S Ramakrishna; V Ingle; J E Dada; M Al Khabori; P S Murty Journal: Int J Pediatr Otorhinolaryngol Date: 2000-08-11 Impact factor: 1.675
Authors: Robert V Skibbens; Jennifer M Colquhoun; Megan J Green; Cody A Molnar; Danielle N Sin; Brian J Sullivan; Eden E Tanzosh Journal: PLoS Genet Date: 2013-12-19 Impact factor: 5.917
Authors: Laurence Gauquelin; Ferdy K Cayami; László Sztriha; Grace Yoon; Luan T Tran; Kether Guerrero; François Hocke; Rosalina M L van Spaendonk; Eva L Fung; Stefano D'Arrigo; Gessica Vasco; Isabelle Thiffault; Dmitriy M Niyazov; Richard Person; Kara Stuart Lewis; Evangeline Wassmer; Trine Prescott; Penny Fallon; Meriel McEntagart; Julia Rankin; Richard Webster; Heike Philippi; Bart van de Warrenburg; Dagmar Timmann; Abhijit Dixit; Claire Searle; Nivedita Thakur; Michael C Kruer; Suvasini Sharma; Adeline Vanderver; Davide Tonduti; Marjo S van der Knaap; Enrico Bertini; Cyril Goizet; Sébastien Fribourg; Nicole I Wolf; Geneviève Bernard Journal: Neurol Genet Date: 2019-10-30